Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir vs Lopinavir in HIV-positive participants
NCT02671383Phase 3Completed
- Start
- Jun 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darunavir in human immunodeficiency virus infection (HIV). Started Jun 2016; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02671383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02671383.